Daniel Isaac

Daniel Isaac is an Assistant Professor in the Division of Hematology and Oncology at Michigan State University. He holds a D.O. from Edward Via College of Osteopathic Medicine at Virginia Tech. His clinical training includes a residency in internal medicine at William Beaumont Hospital (Royal Oak, MI) and a fellowship in Hematology/Oncology at MSU.

• Education: D.O., Edward Via College of Osteopathic Medicine at Virginia Tech
• Residency: Internal Medicine, William Beaumont Hospital
• Fellowship: Hematology/Oncology, Michigan State University

His research focuses on translational oncology, including the efficacy of TCH-165 derivatives in relapsed multiple myeloma and immune microenvironment modulation strategies for prostate cancer. Current work emphasizes drug development pathways and immunotherapeutic approaches in hematologic malignancies.

No scientific awards or grants are explicitly listed in the provided text.